IP Library Granted Patent US 7,741,032
Granted Patent B2
US 7,741,032 · App. 10/887,002 · Granted Jun 22, 2010

Genotyping assay to predict gamma glutamyl hydrolase (GGH) activity

Assignee: St. Jude Children's Research Hospital, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,741,032
App. No.
10/887,002
Granted
Jun 22, 2010
Kind
B2
Abstract

Single nucleotide polymorphisms (SNPs) in the gene encoding gamma glutamyl hydrolase (GGH) associated with reduced GGH activity are disclosed. The primary SNP is a change from a cytosine to a thymine at a position corresponding to nucleotide 511 of Genbank sequence accession no. NM 003878. Methods and kits for detecting these SNPs are provided, along with primers useful in detecting these SNP and for amplifying portions of the GGH gene containing these SNPs.

Claims (4)

1. A method for predicting the level of gamma glutamyl hydrolase (GGH) activity in a human subject comprising determining the nucleotide present in each GGH allele of the genomic DNA of said subject at a position in exon 5 of human GGH corresponding to position 511 of SEQ ID No. 1, wherein presence of cytosine or thymine nucleotides in the GGH alleles is indicative of the level of GGH activity in the subject.

2. The method of claim 1 wherein the step of determining the nucleotide present in each GGH allele of said subject at the selected position is accomplished by sequencing a region of the genomic DNA of said subject which includes said position.

3. The method of claim 1 wherein the step of determining the nucleotide present in each GGH allele of said subject at the selected position is accomplished by (a) amplifying a portion of the genomic DNA of said subject which includes said position to generate an amplified fragment, and (b) treating the amplified fragment with a restriction enzyme in its corresponding restriction buffer to determine the identity of the nucleotide present at said position.

4. The method of claim 1 wherein the step of determining the nucleotide present in each GGH allele of said subject at the selected position is accomplished by (a) amplifying a region of the genomic DNA of said subject which includes said position, and (b) hybridizing the amplified region with multiple probes that vary only at the nucleotide designed to hybridize to the nucleotide at said position, wherein hybridization determines the identity of the nucleotide present at said position.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jun 2, 2011
From: ST JUDE CHILDREN'S RESEARCH HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026381/0366 →
CONFIRMATORY LICENSE Recorded Oct 22, 2008
From: ST. JUDE CHILDREN'S RESEARCH HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021717/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2004
From: EVANS, WILLIAM EDWARD; RELLING, MARY; CHENG, QING
To: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
Reel/Frame 015569/0891 →
Continuity (1)
Related Publication 20060008811A1 · Jan 12, 2006